WELL Health Technologies (TSE:WELL) Announces Quarterly Earnings Results

WELL Health Technologies (TSE:WELL) issued its quarterly earnings data on Thursday. The company reported C$0.04 EPS for the quarter, FiscalAI reports. WELL Health Technologies had a net margin of 1.82% and a return on equity of 3.15%. The company had revenue of C$400.43 million during the quarter.

Here are the key takeaways from WELL Health Technologies’ conference call:

• 2026 guidance was raised: Revenue guidance increased to CAD 1.58–1.65 billion, while adjusted EBITDA guidance rose to CAD 185–195 million. Management cited stronger June performance and higher-margin growth as the basis for the upgrade.
• Canadian operations reached the CAD 100 million adjusted EBITDA run rate milestone three quarters ahead of schedule. WELL Canada’s normalized Q2 adjusted EBITDA grew approximately 56%, supported by clinic growth, margin expansion, and technology-enabled productivity.
• WELL completed the acquisitions of Ontario Imaging Diagnostics and UnionMD, adding approximately CAD 22 million of annual EBITDA and expanding its diagnostics and procedural-health offerings. Management said both businesses performed at or above expectations in their first month.
• WELLSTAR raised CAD 50 million ahead of its expected TSX Venture listing in September, providing capital for acquisitions, AI product development, and organic growth. WELLSTAR generated Q2 revenue of CAD 23 million, up 37% year over year, with a 21% expected 2026 adjusted EBITDA margin.
• Reported Q2 adjusted EBITDA declined 3% to CAD 48.1 million and adjusted net income fell to CAD 11.6 million, while debt increased to CAD 628.7 million following acquisition funding. The company is also pursuing strategic alternatives for its U.S. care assets, but management cautioned that no transaction has reached a disclosure stage.

WELL Health Technologies Price Performance

WELL Health Technologies stock traded up C$0.14 during mid-day trading on Friday, hitting C$4.15. 3,313,001 shares of the company traded hands, compared to its average volume of 1,420,524. The company has a debt-to-equity ratio of 91.15, a quick ratio of 1.02 and a current ratio of 0.83. WELL Health Technologies has a one year low of C$3.58 and a one year high of C$6.08. The stock has a market cap of C$1.06 billion, a price-to-earnings ratio of 37.73, a price-to-earnings-growth ratio of -1.93 and a beta of 0.90. The stock has a fifty day moving average price of C$4.29 and a 200-day moving average price of C$4.15.

Analyst Ratings Changes

WELL has been the topic of several research analyst reports. Stifel Nicolaus upped their price target on shares of WELL Health Technologies from C$8.00 to C$8.25 and gave the stock a “buy” rating in a report on Wednesday, June 3rd. Canadian Imperial Bank of Commerce lifted their price objective on WELL Health Technologies from C$5.50 to C$6.00 and gave the company an “outperformer” rating in a research note on Wednesday, June 3rd. Finally, Canaccord Genuity Group boosted their target price on WELL Health Technologies from C$6.50 to C$7.75 and gave the stock a “buy” rating in a research report on Thursday, July 9th. Four research analysts have rated the stock with a Buy rating, According to data from MarketBeat, the company has an average rating of “Buy” and an average target price of C$7.12.

WELL Health Technologies Company Profile

WELL Health Technologies Corp. (TSX: WELL) is Canada’s largest outpatient healthcare company and a leading provider of technology-enabled healthcare solutions. WELL is building the infrastructure for a healthier Canada, where every patient gets better care, every provider is empowered by AI, and every piece of health data is protected. WELL owns and operates more than 250 clinics in Canada, supporting more than 5 million annual patient visits. Through its subsidiary WELLSTAR, WELL provides electronic medical records, AI-powered clinical tools, patient engagement platforms and IT management services.